Search
  1. Home
  2. East Africa
  3. Kenya

Generic AIDS drugs produced locally

    JOHANNESBURG

    A leading Kenyan drug manufacturer could soon start producing generic versions of HIV/AIDS drugs, local newspaper The East African Standard reported on Tuesday.

    Cosmos Pharmaceuticals Ltd said production of the drugs, mainly for the Kenyan and East African market, would begin within the next month, and was the result of extensive research and development undertaken at its Nairobi facility.

    Dr Prakash Patel, managing director of Cosmos, said the company was currently "waiting for the green light from the government" to commence full-scale manufacturing of the drugs.

    He said the locally produced generics would push the monthly cost of treatment down from about US $46 to $33.

    Cosmos will be Africa's second manufacturer of generic antiretroviral drugs, after the South African company Aspen Pharmacare which announced a similar move earlier this year.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join